Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Aventis Pharma S.A. v. Sandoz Inc. (D. Del. 2009)

See Plans and Pricing

« Back to Dashboard

Aventis Pharma S.A. v. Sandoz Inc. (D. Del. 2009)

Docket   Start Trial Date Filed 2009-10-29
Court District Court, D. Delaware Date Terminated 2012-08-20
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Patents 5,438,072; 5,714,512; 5,750,561
Attorneys Anders T. Aannestad; David C. Doyle; Mark Andrew Woodmansee; Pilar Gabrielle Kraman; Stephen D. Keane; Steven J. Balick; Thomas C. Chen; Tiffany Geyer Lydon
Link to Docket External link to docket
Small Molecule Drugs cited in Aventis Pharma S.A. v. Sandoz Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Aventis Pharma S.A. v. Sandoz Inc. (D. Del. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-10-29 1 Complaint sanofi-aventis patents, including U.S. Patent Nos. 5 ,714,5 12; 5,750,561; and 5,438,072 (collectively,…by reference 31. United States Patent No. 5,438,072 (“the ‘072 patent”), entitled “Taxoid-Based Compositions…. This is a civil action for patent infringement arising under the Patent Laws of the United States, 35…sanofi-aventis’ patents are not infringed and/or invalid. COUNT ONE: INFRINGEMENT OF UNITED STATES PATENT NO. 5,714,512…reference. 11. United States Patent No. 5,714,512 Bl (“the ‘512 patent”), entitled “New Compositions External link to document
2009-10-29 3 Patent/Trademark Report to Commissioner Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,714,512; 5,750,561; 5,438,072; (ksr) (…2009 20 August 2012 1:09-cv-00810 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.